Clinical trial of effects of alogliptin bensoate on endothelial function in type II diabetes mellitus

Trial Profile

Clinical trial of effects of alogliptin bensoate on endothelial function in type II diabetes mellitus

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 13 May 2016

At a glance

  • Drugs Alogliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 25 Mar 2016 Status changed from not yet recruiting to active, no longer recruiting.
    • 25 Mar 2016 Planned End Date changed from 1 Mar 2016 to 1 May 2016.
    • 16 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top